These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3889871)

  • 1. Cardiac electrophysiologic testing: its role in the selection of antiarrhythmic drug regimens for supraventricular and ventricular arrhythmias.
    Cameron J; Isner JM; Salem DM; Estes NA
    Pharmacotherapy; 1985; 5(2):95-107. PubMed ID: 3889871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antiarrhythmic drug efficacy in the treatment of supraventricular arrhythmias.
    Naccarelli GV; Dougherty AH; Berns E; Rinkenberger RL
    Am J Cardiol; 1986 Aug; 58(5):31C-36C. PubMed ID: 3529906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of antiarrhythmic drug therapy by electrophysiologic testing.
    Steinbeck G; Lüderitz B; Andresen D
    Eur Heart J; 1989 Sep; 10 Suppl E():61-5. PubMed ID: 2680504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serial testing of anti-arrhythmia preparations using the intracardiac electrophysiological study of patients with reciprocal paroxysmal tachycardias].
    Sulimov VA; Makolkin VI; Syrkin AL; Papakin GM; Pavlov VV
    Kardiologiia; 1986 Nov; 26(11):30-5. PubMed ID: 3543458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses.
    Hammill SC; Sugrue DD; Gersh BJ; Porter CB; Osborn MJ; Wood DL; Holmes DR
    Mayo Clin Proc; 1986 Jun; 61(6):478-503. PubMed ID: 3520168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical electrophysiology--a decade of progress.
    Denes P; Ezri MD
    J Am Coll Cardiol; 1983 Jan; 1(1):292-305. PubMed ID: 6826939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological evaluation of tachycardias using transesophageal pacing and recording.
    Volkmann H; Kühnert H; Dannberg G
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2044-7. PubMed ID: 1704590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
    Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
    Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
    Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of concealed accessory pathways in supraventricular tachycardia.
    Ross DL; Uther JB
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1069-85. PubMed ID: 6209626
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of electrophysiologic testing in the therapy of ventricular arrhythmias.
    Doherty JU; Josephson ME
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 2):1070-83. PubMed ID: 6195628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of patients with recurrence of ventricular tachyarrhythmias for electrical studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 2):499-504. PubMed ID: 6204307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of accessory atrioventricular pathways in Wolff-Parkinson-White syndrome. Clinical implications.
    German LD; Gallagher JJ
    Am J Med; 1984 Jun; 76(6):1079-86. PubMed ID: 6731464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incessant supraventricular tachycardia.
    Sung RJ
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1306-26. PubMed ID: 6196741
    [No Abstract]   [Full Text] [Related]  

  • 17. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Antiarrhythmic drug therapy.
    Chung EK
    JAMA; 1977 Jan; 237(4):376-9. PubMed ID: 576173
    [No Abstract]   [Full Text] [Related]  

  • 19. Tachyarrhythmias. Application of new information to clinical management.
    Saksena S; Gadhoke A
    Postgrad Med; 1986 Jun; 79(8):121-36. PubMed ID: 3520521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessory atrioventricular conduction syndromes: a review.
    Greene HL
    Johns Hopkins Med J; 1976 Jul; 139(1):13-9. PubMed ID: 948147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.